Supplementary Tables 1 - 5 from Bispecific Antibody to ErbB2 Overcomes Trastuzumab Resistance through Comprehensive Blockade of ErbB2 Heterodimerization

Authors:
  • BLBohua Li
    Bohua Li
  • YMYanchun Meng
    Yanchun Meng
  • LZLei Zheng
    Lei Zheng
  • XZXunmin Zhang
    Xunmin Zhang
  • QTQing Tong
    Qing Tong
  • WTWenlong Tan
    Wenlong Tan
  • SHShi Hu
    Shi Hu
  • HLHui Li
    Hui Li
  • YCYang Chen
    Yang Chen
  • JSJinjing Song
    Jinjing Song
  • GZGe Zhang
    Ge Zhang
  • LZLei Zhao
    Lei Zhao

Abstract
PDF file - 150K, Relative binding affinity of anti-ErbB2 antibodies for the trastuzumab epitope on ErbB2 in BT-474 cells (S1); Relative binding affinity of anti-ErbB2 antibodies for the pertuzumab epitope on ErbB2 in BT-474 cells (S2); Binding affinities of recombinant anti-ErbB2 antibodies for ErbB2-ECD (S3); Pharmacokinetic parameters of recombinant anti-ErbB2 antibodies in mice (S4); ErbB receptor expression on breast cancer cell lines (S5).